Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

Clinical trial NCT01785875 · COMPLETED

Trial details

NCT number: NCT01785875
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hyperparathyroidism, Secondary

Start date: 2013-07-31
Primary completion: 2015-07-01
Enrollment: 891

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.